Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
AbbVie U-Turns On Dong-A’s MerTK Program After Development Delays
Jul 12 2021
•
By
Jung Won Shin
Dong-A Yet To Determine New Development Plans after abbvie u-turn • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from South Korea
More from Focus On Asia